Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity

Transplantation

Volumn 76, Issue 8, 2003, Pages 1229-1231

  Sester, Martina ^a   Gärtner, Barbara C ^a   Sester, Urban ^a   Girndt, Matthias ^a   Mueller Lantzsch, Nikolaus ^a   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMORAL IMMUNITY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE;

ADULT; AGED; ANTIBODY FORMATION; COHORT STUDIES; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; MIDDLE AGED; SEROLOGIC TESTS;

EID: 0242332167     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000083894.61333.56     Document Type: Article

References (10)

1. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741.
2. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Immunol Today 2000; 21: 447.
3. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038.
4. Sester M, Sester U, Gärtner B, et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001; 71: 1287.
5. Sester M, Sester U, Gärtner B, et al. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J Virol 2002; 76: 3748.
6. Lowance D, Neumayer HH, Legendre CM, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation: International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999; 340: 1462.
7. Becker BN, Becker YT, Leverson GE, et al. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Am J Kidney Dis 2002; 39: 1088.
8. Smiley ML, Wlodaver CG, Grossman RA, et al. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 1985; 40: 157.
9. Kaufman DB, Leventhal JR, Gallon LG, et al. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation. Transplantation 2001; 72: 1940.
10. Koerner K, Freudenberg J, Kubanek B. Blood donor selection in providing anticytomegalovirus-negative blood components. Dtsch Med Wochenschr 1989; 114: 203.